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ABSTRACT
Residentmesenchymal stromal cells (MSCs) are involved inangiogenesis during thymus regeneration.
We have previously shown that MSCs can be isolated from enzymatically digested human neonatal
and infant thymus tissue that isnormallydiscardedduringpediatric cardiac surgical procedures. In this
paper,wedemonstrate that thymusMSCs can also be isolated by explant culture of discarded thymus
tissue and that these cells share many of the characteristics of bone marrowMSCs. Human neonatal
thymus MSCs are clonogenic, demonstrate exponential growth in nearly 30 population doublings,
have a characteristic surface marker profile, and express pluripotency genes. Furthermore, thymus
MSCs have potent proangiogenic behavior in vitro with sprout formation and angiogenic growth fac-
tor production. ThymusMSCs promote neoangiogenesis and cooperatewith endothelial cells to form
functional human blood vessels in vivo. These characteristics make thymus MSCs a potential candi-
date for use as an angiogenic cell therapeutic agent and for vascularizing engineered tissues in vitro.
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INTRODUCTION
Mesenchymal stromal cells (MSCs) isolated
from bone marrow, a tissue with regenerative
abilities [1, 2], are being evaluated for degener-
ative and acquired diseases of tissues and
organs (e.g., the heart) that may have relatively
limited intrinsic regenerative potential [3]. The
human thymus is a vascularized organ that plays
a pivotal role in T-lymphocyte development,
and its durability in providing a robust acquired
immune response throughout the lifespan may
be partially attributed to its ability to regener-
ate after injury, infection, or partial surgical re-
section. A brisk angiogenic phase that involves
the participation of MSCs supports thymus re-
generation [4, 5]. The in vivo regenerative and
proangiogenic function of resident MSCs in
the thymus makes them a potential candidate
as a cell therapeutic agent in ischemic diseases
of other tissues.
According to the Society of Thoracic Surgeons
National Database, severe congenital heart dis-
ease requiring surgical correction in the neonatal
and infantperiodoccurs in.10,000patients each
year in the U.S. Partial or subtotal thymus resec-
tion is required to expose the heart and great ves-
sels duringmanyof these surgical procedures.We
and others have identified this normally dis-
carded tissue as a plentiful source of MSCs
obtained by enzymatic digestion [6, 7]. However,
the use of dissociative enzymes and subsequent
washes are significant additional steps for clinical
translation of these MSCs into patients and may
yield numerous other thymus cell types, such as
thymic epithelial cells.
The objective of this investigation was two-
fold. First, we characterized MSCs isolated by ex-
plant culture of mechanically fragmented human
neonatal and infant thymus tissue. Second, we in-
vestigated the in vitro and in vivo proangiogenic
qualities of explant culture-isolated human neo-
natal thymus MSCs. Our results indicate that dis-
carded human neonatal thymus tissue is a source
of MSCs with angiogenic potential.
MATERIALS AND METHODS
Cell Isolation and Culture
All studies were performed under an approved
protocol from the University of Michigan institu-
tional review board. After informed consent was
given by the parents, discarded thymus tissue
from infant heart operations was mechanically
minced and subjected to explant culture. Experi-
mental details are shown in the supplemental
onlinedata.Unless specifiedotherwise, all experi-
ments were performed with cells from passages
3–9.
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Thymus MSC Isolation Yield Estimate
Thymus tissue fragments from 4 patients were weighed and
placed in 35-mm tissue culture dishes for explant culture (3–4
fragments per patient). After 10 days of culture, tissue fragments
were removed, and the number of cells in each dishwas counted.
The average number of cells per gram of tissue was then
calculated.
CFU-F Efficiency and Limiting Dilution Assay
All colony-forming unit (CFU) assays were performed with pas-
sage 7 thymus MSCs from 8 patients. Experimental details of
CFU efficiency (CFE) determination are shown in the sup-
plemental online data. Colonies with .50 cells were counted
and recorded.
Fibroblastic CFU (CFU-F) prevalence was also estimated by
a limiting dilution assay (LDA) [8]. Experimental details are shown
in the supplemental online data. CFU-F frequencywas then calcu-
lated using L-Calc software (Stemcell Technologies, Vancouver,
BC, Canada, http://www.stemcell.com).
Thymus MSC Growth Kinetics
Growth kinetics of thymusMSCs isolated from four patients were
studied with a cumulative population-doubling analysis. Experi-
mental details are shown in the supplemental online data.
Flow Cytometric Analysis
Surface markers of passage 4–9 thymus MSCs isolated from 6
patients were characterized by flow cytometry using antibodies
against CD29, CD44, CD45, CD90, CD105, CD73, CD166, CD49e,
CD56, STRO-1, CD271, SSEA-4, HLA-ABC, HLA-DR, and nestin. Ex-
perimental details are shown in the supplemental online data.
Pluripotency Gene Expression Analysis
Expressionof pluripotency-related genesOct-4, Sox-2, andNanog
was determined in thymusMSCs (passage 5 or 6, n = 5) relative to
human induced pluripotent stem cells using quantitative poly-
merase chain reaction (qPCR). Experimental details are shown
in the supplemental online data.
Multilineage Differentiation
The ability of thymusMSCs isolated from three patients to differ-
entiate into osteogenic, adipogenic, and chondrogenic lineages
when cultured in specific differentiation media was investigated.
Experimental details are shown in the supplemental online data.
CD248 Expression
Expression of CD248 (endosialin) on neonatal human thymus
MSCs was performed by immunofluorescent staining. Experi-
mental details are shown in the supplemental online data.
Two-Dimensional Angiogenesis Assay
A two-dimensional (2D) in vitro assay was performed to investi-
gatewhether thymusMSCs,withorwithouthumanumbilical vein
endothelial cells (HUVECs), induced tube formation. Experimen-
tal details are shown in the supplemental online data.
Multicellular Spheroid Generation
HUVEC, thymus MSC, and HUVEC plus thymus MSC spheroids
used in the three-dimensional (3D) angiogenesis assay and in
vivo experiments were created by hanging drop culture. Ex-
perimental details are shown in the supplemental online
data.
Fluorescent Labeling of Cells and Spheroid Sprouting
Time Course Study
HUVECs and thymus MSCs were labeled with the vital cell dyes
PKH26 and PKH67, respectively, according to the manufac-
turer’s directions (Sigma-Aldrich, St. Louis, MO, https://www.
sigmaaldrich.com). Nuclei were stained with Hoechst 33342
(Molecular Probes, Life Technologies; Thermo Fisher Scientific,
Waltham, MA, http://www.thermofisher.com/en/home.html).
After completion of the labeling, spheroids were generated as
described above and imaged consecutively at 0, 24, and48hours
after placement in fibrin hydrogel with a confocal microscope.
Independent experiments were performed in triplicate.
3D Angiogenesis Assay
Fibrin hydrogel was generated in eachwell of a 24-well plate, as
described, followed by the addition of 75 spheroids per well
prior to polymerization to ensure that spheroids were embed-
ded within the hydrogel. There were three spheroid groups:
HUVECs, HUVECs plus thymus MSCs, and thymus MSCs. After
fibrinogen polymerization, basal EGM-2 was added to each
well. Spheroids were then incubated overnight and imaged
at3100 using an inverted phase contrastmicroscope (20 sphe-
roids per group). Images were digitally acquired and then
analyzed using NeuronJ plugin (Erik Meijering, http://www.
imagescience.org/meijering/software/neuronj/) for ImageJ
software (NIH, Bethesda, MD, http://imagej.nih.gov/ij/). Pri-
mary sprouts emanating from each spheroid were measured
by tracing from the base to the furthest tip. Branches from pri-
mary sproutsweremeasured from their origin to the tip. Cumu-
lative branch length and total number of branches were then
calculated for each spheroid. Spheroids located along the edge
of the wells or in close proximity to each other were excluded
from image analysis. Independent experiments were per-
formed in triplicate. In separate experiments, we explored
the effects of modifying the ratio of cell types in combination
cell spheroids with thymus MSC/HUVEC ratios of 1:3, 1:1,
and 3:1 on spheroid sprouting.
Angiogenic Gene Expression Analysis
To gain insight into the findings demonstrated by the spheroid
and monolayer sprouting assays, we evaluated differential gene
expression for VEGFA, bFGF, and HIF-1a in the different groups
and culture conditions using qPCR. After 48 hours, fibrin gels
containing spheroids or cell monolayers were digested with
nattokinase (50 fibrinolytic units per milliliter, NSK-SD; Japan Bio
Science Laboratory Co., Ltd, Osaka, Japan, http://jbsl-net.com/
english/index.html) [9] prior toRNA isolationandqPCR. The effects
of modifying the ratio of cell types in combination cell spheroids
with thymus MSC/HUVEC ratios of 1:3, 1:1, and 3:1 on angiogenic
gene expression were also investigated. Experimental details are
shown in the supplemental online data and supplemental online
Table 1.
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Enzyme-Linked Immunosorbent Assay
Vasculogenic andangiogenic growth factor (VEGFAandbFGF) lev-
els in supernatants were measured using enzyme-linked im-
munosorbent assay kits (VEGFA kit: Invitrogen, Life Technologies,
Thermo Fisher Scientific; bFGF kit: Abcam, Cambridge, MA,
http://www.abcam.com), according to themanufacturer’s direc-
tions. To investigate the effects of the combinations of HUVECs
and thymus MSCs on growth factor production, HUVEC, thymus
MSC, andHUVECplus thymusMSC spheroidswere generated and
embedded in fibrin gel in a 12-well plate (500 spheroids per well),
and supernatants were collected after 48 hours of culture for
analysis. Independent experiments were performed in triplicate.
In Vivo Assessment of Thymus MSC-Induced
Angiogenesis
The care of animals was in accordance with institutional guide-
lines. Constructs (3 per group) containing 500 spheroids (HUVECs,
thymus MSCs, and HUVECs plus thymus MSCs) or no spheroids
(control group) were made in 96-well plates with 200 ml of fibrin
hydrogel and then were implanted subcutaneously in the dorsal
region of NOD/SCID mice (Charles River Laboratories Interna-
tional, Wilmington, MA, http://www.criver.com). Constructs
were explanted 14days after implantation, fixedwith 4%parafor-
maldehyde, serially dehydrated in ethanol solutions, infiltrated
with xylene, and then embedded in paraffin. Paraffin blocks were
sectioned at 5-mm thickness, mounted on glass slides, and then
stained with hematoxylin and eosin. The vessel density within
and adjacent to the constructs (between the panniculus carnosus
muscle layer and the superficial aspect of the construct) was de-
termined. Details on vessel density quantification are shown in
the supplemental online data. To determine the origin of blood
vessels identified within and adjacent to the construct, immuno-
histochemical analysis was performed using a monoclonal anti-
body specific for human CD31 (Dako, Carpinteria, CA, http://
www.dako.com) along with the appropriate secondary antibod-
ies. Cell nuclei were counterstained with hematoxylin. To deter-
mine the possibility of natural killer (NK) cell involvement in the
observed angiogenesis surrounding and within the construct,
a separate group of HUVEC plus thymus MSC constructs were
explanted on day 7 (when early infiltrate would have been
expected) and evaluated for CD335 (BioLegend, San Diego, CA,
http://www.biolegend.com), a NK cell marker.
Statistical Analysis
Data were expressed as mean 6 SD. Statistical differences be-
tween multiple groups were determined using one-way analysis
of variance (ANOVA) with post hoc Tukey honestly significant dif-
ference test. Two-way ANOVA with post hoc Tukey honestly sig-
nificant difference test was used to analyze angiogenic gene
expression and vessel density data. Significance was defined as
a p value,.05.
RESULTS
Characterization of Explant Culture Isolated Neonatal
Human Thymus MSCs
Thymus MSCs were isolated from 10 different neonates and
infants (aged 2–150 days; mean age: 516 61 days) who carried
a diagnosis of hypoplastic left heart syndrome, D-transposition of
the great arteries, pulmonary atresia, complete atrioventricular
septal defect, aortic arch hypoplasia, tetralogy of Fallot, and pul-
monary artery sling by using an explant culturemethod. Only thy-
musMSCs frompatients with an absence of known chromosomal
abnormalities (n = 8) were evaluated. Discarded thymus tissue
wasmechanically minced under sterile conditions in the operating
room (Fig. 1A, 1B). After 5–10 days of culture, elongated cells
with fibroblastic morphology migrated from thymus tissue
onto the culture surface (Fig. 1C). An average of (1.95 3 105) 6
(2.713 105) plastic-adherent cellswithMSCmorphology per gram
of thymus tissuewas isolated by using this explant culturemethod
(n = 4).
Clonogenicity of thymus MSCs (all between passages 4–9)
was evaluated by CFE and CFU-F frequency by limiting dilution
assays. Twoweeks after plating thymusMSCs (n=7),weobserved
a CFE of 20%–57% (Fig. 1D, 1E). Using the LDAmethod (n = 9), we
found that CFU-F frequencywas an averageof 1 in 166 (range: 1 in
31 to 1 in 467).
We evaluated the growth kinetics of thymus MSCs isolated
from four patients. Thymus MSCs displayed exponential growth
in nearly 30population doublings (Fig. 1F). Average doubling time
for these thymus MSCs during this period was 2.856 0.54 days.
Human neonatal thymus MSCs from three different patients
differentiated into adipogenic, osteogenic and chondrogenic lin-
eages (Fig. 2A–2D). By flow cytometric analysis, human neonatal
thymusMSCs from five different patients were nearly all positive
for CD44, CD90, CD29, CD105, CD73, and CD166 and negative for
CD45, HLA-DR, CD56, STRO-1, SSEA-4, and nestin (Fig. 2E). Ap-
proximately 1%–3% of thymus MSCs were also negative for
HLA-ABC.
Human MSCs are also known to express pluripotency genes
during early passages, and that may contribute to their regener-
ative abilities [10–13]. We investigated this characteristic in thy-
musMSCs (n =5, passage 5or 6)with qPCRand found that thymus
MSCs expressed low levels of Oct-4, Nanog, and Sox-2 gene ex-
pression (supplemental online Fig. 1). All lines that were evalu-
ated consistently expressed low levels of Oct-4, whereas there
was more variability in the expression of Nanog and Sox-2.
Proangiogenic Characteristics of Thymus MSCs
Because CD248-positive thymus MSCs have been demonstrated
to contribute toangiogenesis duringmurine thymus regeneration
[5], we determined whether human thymusMSCs also expressed
this surface marker. With immunofluorescence staining, we
found that human thymus MSCs (n = 6) were all positive for
CD248 (supplemental online Fig. 2).
We evaluated the in vitro proangiogenic characteristics of
thymus MSCs combined with HUVECs using a conventional 2D
monolayer method and a quantitative 3D spheroid sprouting as-
say because 3D culture ofMSCs has been demonstrated to poten-
tiate their proangiogenic effects andmay bemore representative
of their in vivo behavior [14, 15].
It is well known that HUVECs cultured on Matrigel form a tu-
bule network after overnight culture [16]. We chose to use fibrin
hydrogel instead ofMatrigel to eliminate the effects of the angio-
genic growth factors contained in the latter. We observed that
HUVECs culturedon fibrin hydrogel didnotmanifest anyevidence
of tubulogenesis at 48 hours of culture (Fig. 3A). Thymus MSCs
tended to cluster together and form multicellular masses when
cultured on fibrin hydrogel (Fig. 3B). The combination of thymus
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MSCs and HUVECs on fibrin hydrogel yielded an interconnected
honeycomb tubule network (Fig. 3C).
Multicellular spheroids embedded in fibrin hydrogel were
used for the 3Dassessment of angiogenesis. Spheroids composed
only of HUVECs did not manifest much sprouting at 16 hours (Fig.
4A). Spheroids composed of only thymus MSCs demonstrated
variable sprouting that was dependent on the donor (Figs.
4B–4F).However, spheroidswith the combinationofHUVECsplus
thymus MSCs formed extensive, radiating, tubule-like structures
within 16 hours, regardless of donor source of thymusMSCs (Fig.
4G, 4H). The morphology of the sprouts was also distinct in that
the combinationHUVECplus thymusMSC spheroids had themost
complex branching pattern compared with the thymusMSC-only
group (Fig. 4I). At 72 hours, sprouts fromHUVECplus thymusMSC
spheroids were more extensive and appeared to anastomose
with those from adjacent spheroids (Fig. 4J). We had arbitrarily
chosen a 3:1 ratio of HUVECs to thymus MSCs (3:1) because we
speculated that endothelial cells (ECs) would outnumber MSCs
in vivo based on separatemeasures ofMSCs and ECs in bonemar-
row [17–19].We also repeated these sprouting experiments with
aHUVEC/thymusMSC ratioof1:3and1:1 and foundno significant
differences in branch number, and the 1:1 ratio group demon-
strated longer total branch length (supplemental online Fig 3).
To understand the contribution of the different cell types to
spheroid sprout formation, HUVECs and thymus MSCs were la-
beledwith vital dyes PKH67 and PKH26, respectively. Fluorescent
labeling in the combination group of HUVECs plus thymus MSCs
revealed that after spheroid formation,MSCs composed the core
of the spheroid, whereas the HUVECs remained in the periphery
(Fig. 5). After allowing the spheroids to sprout, the thymus MSCs
migrated to form the leading edge of the sprouts, whereas the
HUVECs composed the core of the spheroid. At 8 hours, many
of these sprouts originated from the thymus MSCs, with HUVECs
colocalized to a subset of the bases of these sprouts (Fig. 5). At 24
hours, the sprouts had increased in number, complexity, and
length. Again, many of the sprouts were composed of thymus
MSCs; however, a larger subset also containedHUVECs, which ex-
tended further out from the base compared with those observed
at the 8-hour time point (Fig. 5).
Thymus MSC Angiogenic Gene and Protein Expression
To gain further insight into the angiogenic sprouting seen in 3D
versus 2D culture conditions and the effects of cell composition
(HUVECs, thymus MSCs, and HUVECs plus thymus MSCs) on
spheroid sprouting, we investigated changes in expression for
genes known to play a role in angiogenesis and vasculogenesis:
VEGFA,bFGF, andHIF-1a. CulturingHUVECs in spheroids resulted
in a decrease in expression of all studied genes compared with
monolayer culture. However, placing thymus MSCs in spheroid
form had varying effects on the genes (Fig. 6A). For VEGFA, ex-
pression decreased when thymus MSCs were cultured in sphe-
roids (Fig. 6A). For bFGF and HIF-1a, expression increased from
two to five times when culturing thymus MSCs in spheroid form
(Fig. 6A). In monolayer and spheroid culture, thymus MSCs had
similar levels of VEGFA expression. Relative to thymus MSCs in
spheroid form, we noted that combining HUVECs with thymus
MSCs resulted in an increase in VEGFA expression; however, in
this combination of cell types, the expression of bFGF or HIF-1a
did not change or slightly decreased (Fig. 6A). Increasing the
thymus MSC content of spheroids resulted in an increase in
VEGFA, bFGF, and HIF-1a gene expression (supplemental online
Fig 3).
Figure 1. Discarded human neonatal thymus tissue is a source of mesenchymal stromal cells (MSCs). (A): Discarded human neonatal thymus
tissue during pediatric cardiac surgery. (B): Minced thymus tissue prior to plating. (C): Cells migrating from thymus tissue fragments during
explant culture at 10 days. (D): Clonogenicity of thymusMSCs at 2 weeks (representative of 7 donors). (E): Colony-forming efficiency of thymus
MSCs. (F): Averaged cumulative population doubling of thymus MSCs (n = 4) over 9 weeks of culture. Abbreviation: CFU-F, fibroblastic colony-
forming unit.
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Monolayer and spheroid VEGFA and bFGF gene expression
changes were confirmed by measuring protein levels in superna-
tants (n = 3) (Fig. 6B, 6C). We found that HUVEC spheroids had
undetectable VEGFA levels, whereas supernatant VEGFA levels
inboth thymusMSCspheroids andHUVECplus thymusMSCsphe-
roids were significantly higher. Supernatant VEGFA levels were
not different in HUVEC plus thymus MSC spheroids compared
with thymus MSC spheroids (Fig. 6B). Supernatants from HUVEC
spheroids contained low levels of bFGF. Thymus MSC spheroids
had significantly higher levels of bFGF in the supernatant com-
paredwithHUVECspheroids. ThecombinationofHUVECplus thy-
musMSC spheroids yielded the greatest concentration of bFGF in
Figure 2. Characterization of human neonatal thymus mesenchymal stromal cells (MSCs) isolated by explant culture. (A): Oil Red O staining
representing adipogenic differentiation after differentiation with adipogenic-differentiation media. (B): FABP-4 expression on thymus MSCs
after differentiation with adipogenic-differentiation media. (C): Osteocalcin expression on thymus MSCs after differentiation with osteo-
genic-differentiationmedia. (D):Aggrecanexpressionon thymusMSCs after differentiationwith chondrogenic-differentiationmedia. All results
are representative of three independent experiments. (E): Flow cytometric profile of thymus MSCs. All results are representative of thymus
MSCs isolated from five to seven patients. Scale bar = 50 mm.
Figure 3. Thymus mesenchymal stromal cells (MSCs) cooperate with human umbilical vein endothelial cells (HUVECs) to form a network in
a two-dimensional angiogenesis assay. (A):Monolayer appearance of HUVECs after 48 hours of culture on fibrin hydrogel. (B): Thymus MSCs
clustered together after 24 hours of culture on fibrin hydrogel. (C): Combining HUVECs with thymus MSCs (2:1) resulted in the appearance of
interconnected tubules at 24 hours. Scale bars = 100 mm. Results are representative of two independent experiments.
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the supernatant (p, .05vs. supernatants frombothHUVECsphe-
roids and thymus MSC spheroids) (Fig. 6C).
Thymus MSCs Promote In Vivo Vascularization
We evaluated the function of spheroid angiogenic sprouts by
implanting fibrin hydrogel constructs containing no cells or sphe-
roids composed of HUVECs, thymus MSCs, and HUVECs plus thy-
musMSCs subcutaneously in NOD-SCIDmice. On explant, control
constructs did not appear tomanifest any adjacent host reaction,
whereas the constructs with spheroids made of thymus MSCs or
HUVECs plus thymus MSCs incited an obvious host vascular re-
sponse (Fig. 7A–7D).
Histologically, controls demonstrated cellular (but avascular)
infiltrate from the surrounding tissue. No blood vessels were de-
tectable within the control constructs, and the region adjacent
to the construct did not appear to have increased vascularity
(Fig. 7E).
Constructs with spheroids from all groups shared several
characteristics. First, the central portions of the construct demon-
strated “ghosts,” or empty pockets, that were indicative of the
prior locations of spheroids (Fig. 7F). There were also spheroids
within the more interior portions of the constructs that mani-
festedvaryingdegreesof cell death, suggesting that the cellswere
subjected to ischemia (Fig. 7F). However, spheroids were gener-
ally present at the surface of the construct, suggesting that an ad-
equate level of tissue partial pressure of oxygen was present to
sustain the survival of these cells. All spheroid groups had an in-
creased cell number and vascularity adjacent to the construct.
This increase in vascularity was specifically identified between
the panniculus carnosusmuscle layer and themore superficial as-
pect of the construct, whereas no blood vessels were identified
deep in the construct (Fig. 7F). This finding suggests that
implanted constructs attracted host blood vessels frommore su-
perficial (and vascular) regions of the mouse dermis. Any vascu-
larization within a construct occurred at its surface, consistent
with the findings of others [20].
Constructs composed of spheroids made of only HUVECs
attracted host blood vessels adjacent to the construct but had
few vessels penetrate the construct (Fig. 7F). Constructs com-
posed of thymus MSC-only spheroids demonstrated increased
cellularity andvascularity surroundingandpenetrating these con-
structs (Fig. 7G). Constructs containing spheroids with both
HUVECs and thymus MSCs also demonstrated an increase in ad-
jacent tissue cellularity and vascularity and had the greatest ves-
sel density within the construct (Fig. 7H, 7I). In some regions
adjacent to constructs with thymusMSC-only or HUVEC plus thy-
mus MSC spheroids, we noted significant erythrocyte extravasa-
tion (data not shown).
To determine the origin of the new blood vessels identified
within the constructs, we performed human-specific CD31 stain-
ing. We found that only constructs with spheroids containing
HUVECs plus thymus MSCs (n = 3) contained human-specific
CD31 luminal structures that contained erythrocytes, suggesting
Figure 4. Thymus MSCs cooperate with HUVECs to promote tubule formation in a spheroid three-dimensional (3D) angiogenesis assay. (A):
Spheroids composed of HUVECs and embedded in fibrin hydrogel did not manifest any sprouting after 16 hours. (B–F): Spheroids composed of
thymusMSCs isolated fromdifferentdonorsmanifested varyingdegreesof tubule formationat 16hours. (G,H):Spheroids composedofHUVECs
plus thymus MSCs (regardless of donor) all demonstrated extensive branching tubule formation at 16 hours. Scale bars = 100 mm. (I): Quan-
titative analysis of 3D angiogenesis assay with HUVEC plus thymus MSC spheroids demonstrating the greatest cumulative branch length and
total number of branches (n = 20 spheroids per group). (J): Spheroids composed of HUVECs plus thymus MSCs demonstrated complex, anas-
tomosing branches at 72 hours. Results are representative of three independent experiments. Abbreviations: HUVEC, human umbilical vein
endothelial cell; MSC, mesenchymal stromal cell.
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the formation of functional human vessels that integrated with
the host’s vasculature (Fig. 7J). Human CD31-positive vessel den-
sity from five sections of these HUVEC plus thymus MSC con-
structs was determined to be 20.9 6 10.6 vessels per square
millimeter. We did not find any positive CD335 NK cells within
or around day 7 explants (supplemental online Fig. 4).
DISCUSSION
One aim of this study was to isolateMSCs from discarded thymus
tissue using a nonenzymatic, explant culture technique. Digestive
enzymes may damage and/or alter cells and complicate the gen-
eration of a cell therapeutic product under good manufacturing
practice conditions [21, 22]. Similar to our approach in this study
with discarded thymus tissue, others have described the efficient
isolation of adipose stem cells by explant culture of lipoaspirate
tissue fragments [23–25]. It was not the purpose of our study
to optimize MSC isolation from discarded thymus tissue using
a manual fragmentation method, and this may explain the vari-
ability in the yield that we observed with different samples. How-
ever, compared with published results of the isolation of MSCs
from adipose tissue, our method of isolating MSCs from thymus
tissue appears to provide a comparable yield [26].
We have extended the prior characterization of MSCs from
discarded neonatal human thymus tissue isolated by an enzy-
matic method [6, 7]. In this study, we demonstrated that explant
culture-isolated thymus MSCs share many characteristics with
bone marrow-derived MSCs. The prevalence of thymus MSC
CFU-Fs is comparable to that determined for bone marrow and
adipose tissue MSCs [27, 28]. The average thymus MSC doubling
was also comparable to those ofMSCs isolated fromother tissues
[29]. Various types of MSCs have been shown to express pluripo-
tency genes [10–12]. We demonstrated that passage 5 and 6 thy-
mus MSCs exhibited low levels of Oct-4, Nanog, and Sox-2 gene
expression and were also multipotent. ThymusMSCs shared sev-
eral surface marker characteristics with bone marrow MSCs but
also, like MSCs from other tissues, were distinct in that they
lacked some of themarkers that have been used to identify a sub-
set of bone marrow MSCs such as STRO-1 [30–32]. Unlike amni-
otic fluid MSCs, neonatal thymus MSCs did not express SSEA-4
[32].
Organ and tissue regeneration requires growth of new tissue
or repair of damaged tissue that contributes relevant, organ-
specific, physiological function. The regenerative capacity of
humanorgans varies considerably. Althoughheart, brain, and kid-
neys appear to have limited regenerative potential after injury,
the preadolescent thymus gland possesses an extraordinary abil-
ity to regenerate itself after injury and stress. Fundamental to any
significant regenerative response of thick tissues and to the engi-
neering of viable thick tissues is the requirement of angiogenesis
and vasculogenesis; therefore, regenerative medicine strategies
should include components that boost neovascularization
[33–37].
We found that thymus MSCs possess proangiogenic charac-
teristics in vitro and in vivo. Although bone marrow MSCs form
a tubule network when cultured on Matrigel [38, 39], thymus
MSCs tended to cluster together to formmicrocellular aggregates
on fibrin hydrogel. This different behavior may be attributable to
Figure 5. ThymusMSCs initiate the spheroid sprouting response in vitro. HUVECs and thymusMSCswere labeledwith PKH26 and PKH67 prior
to spheroid formation by overnight hanging drop culture and then embedded in fibrin hydrogel. Spheroids were then imaged with a confocal
microscope at the indicated time points. As seen at 0 hour, spheroids with HUVECs and thymus MSCs formed core-shell bodies with MSCs
forming the interior core of the spheroid. Spheroids manifested sprouting at 8 hours, with thymus MSCs composing the majority of sprouts
and HUVECs colocalized to the bases of a subset of sprouts. At 24 hours, spheroids hadmore extensive branches, all composed of thymusMSCs
and a subset containing HUVECs as well. Scale bars for 0- and 8-hour images = 50 mm. Scale bars for 24-hour images = 100 mm. Results are
representative of three independent experiments. Abbreviations: HUVEC, human umbilical vein endothelial cell; MSC, mesenchymal stromal
cell.
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the composition and biomechanical properties of the fibrin
hydrogel [40].WhenHUVECs and thymusMSCswere cultured to-
gether, a honeycomb tubule network rapidly developed on fibrin
hydrogel, suggesting that the additionofHUVECs altered the clus-
tering and contractile behavior of the thymus MSCs.
We also evaluated the angiogenic characteristics of thymus
MSCs using an established 3D sprouting assay [41–43] because
3D culture is known to enhance the regenerative abilities ofMSCs
andmore closely approximates the in vivo setting [44–47]. Inmul-
ticellular spheroids, HUVECs and thymus MSCs are in a 3D, high-
cell-density aggregate during initial formation, facilitating direct
contact and paracrine cell interactions. These cell interactions
can be homotypic (MSC/MSC and EC/EC) or heterotypic (EC/
MSC). Although it is clear that thymus MSC spheroids had wide-
spread upregulation of gene expression because of homotypic
interactions, the slightly decreased upregulation in angiogenic
gene expression in the combination of HUVEC plus thymus
MSC spheroids suggested that HUVECsmay temper this response
(heterotypic interactions) or that thismay be a dilutional effect of
the HUVEC mRNA that decreases the thymus MSC mRNA signal
during qPCR. The decrease in angiogenic gene expression caused
by an increase in the ratio ofHUVECs to thymusMSCs in spheroids
is consistent with either explanation. Regulation of MSCs by
endothelial cells in vasculogenesis and angiogenesis has not been
delineated in detail and is an area of needed research.
Lee et al. described large core-shell bodies (5,000 cells per
spheroid) composed of HUVECs and bone marrow MSCs, with
MSCs forming the core and HUVECs forming the shell [48]. These
investigators used a two-step process that took 48 hours to force
a core-shell body arrangement, and the sprouting from these
spheroids was seen first at day 3 after embedding in Matrigel.
Our method used overnight hanging drop culture to generate
spheroids that demonstrated long sprouts in fibrin hydrogel
within 16 hours. The improved sprouting may have been second-
ary to the difference in angiogenic properties of thymus versus
bone marrow MSCs, and allowing thymus MSCs and HUVECs to
comingle with each othermay havemaximized contact and inter-
actions between both cell populations before they sorted into
a core-shell formation. The improved sprouting we observed
may also be explained by the differences in surrounding matrix
and their biophysical properties, which can affect the sprouting
response [40, 49].
Recruited supporting cells stabilize nascent angiogenic
sprouts [50–53]. Placing thymus MSCs and HUVECs together in
spheroids eliminates the recruitment step, potentially explaining
the rapid sprouting observed in the heterotypic cell combination
Figure 6. Increased angiogenic gene and protein expression in thymus MSCs. HUVECs and thymus MSCs were cultured as monolayer or in
spheroids for 48 hours prior to RNA isolation for quantitative polymerase chain reaction analysis. (A): Fold change in expression for HIF-1a,
VEGFA, and bFGF relative to HUVECs cultured in spheroids. In general, monolayer and spheroids with thymusMSCs had significantly increased
expression of all studied genes. Culturing thymus MSCs in spheroids enhanced the expression of these angiogenic genes. For each gene, all
comparisons between groups were significant by two-way analysis of variance (ANOVA) and post hoc Tukey test except those comparisons
indicated by an asterisk. (B, C): Levels of VEGFA and bFGF in supernatants from spheroid cultures in (A) were determined by enzyme-linked
immunosorbent assay. VEGFA levels were increased in spheroids containing thymus MSCs, with no apparent effect by culturing with HUVECs.
There was no difference in VEGFA levels between thymusMSC and HUVEC plus thymusMSCs groups. In contrast, bFGF levels were significantly
higher in spheroids containing both HUVECs and thymus MSCs. Results are representative of three independent experiments. Comparisons
were performed by one-way ANOVA with post hoc Tukey test. Abbreviations: 2D, two-dimensional; 3D, three-dimensional; HUVEC, human
umbilical vein endothelial cell; MSC, mesenchymal stromal cell.
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spheroids. It has been speculated that the relative availability of
supporting cell-secreted growth factors and their diffusion dis-
tance from supporting cells to endothelial cells affects the robust-
ness of tubule formation; therefore, minimizing the distance
between endothelial and supporting cell, as in spheroids, may
promote microvascularization [49]. In this study, we also found
that thymus MSCs may lead the angiogenic sprouting response;
this is a new angiogenesis and vasculogenesis paradigm because
tip endothelial cells are thought to lead the formation of new
sprouts [54–56].
Because of the small diameter of the spheroids that we used,
whichwas well within the oxygen diffusion distance, hypoxia was
not expected; however,HIF-1a gene expression was upregulated
when thymusMSCswere cultured in spheroid form versusmono-
layer, suggesting a hypoxic response. One possible explanation of
this finding is that the oxygen consumption rate for thymusMSCs
may be high (or increased during spheroid culture) such that the
hypoxia is present at the core of these relatively small spheroids.
The combination of thymusMSCs and HUVECs in spheroids dem-
onstrated a decrease in supernatant VEGFA levels. This may rep-
resent consumption or binding of VEGFA by HUVECs and/or
negative regulation of MSCs by HUVECs and represents an area
of future study.
The thymus gland involutes after infection, injury, and che-
motherapy [57]. Resolution of thymic stress initiates a potent
regenerative response in the thymusgland.Underlying the regen-
erative potential of the thymus gland is a brisk angiogenic re-
sponse [4, 5]. This response has been investigated in rodents
but has been poorly characterized in humans [4, 5]. Sepsis during
the neonatal period has been demonstrated to cause involution
[58]. CD248-positive MSCs significantly contributes to the angio-
genic response of thymus regeneration in mice [5]. In this study,
we demonstrated that thymus MSCs expressed CD248, a cell-
surface receptor associated with cell adhesion and migration
Figure 7. Thymus mesenchymal stromal cells (MSCs) incite angiogenesis in vivo. Fibrin constructs without spheroids (control) or with 500
spheroids with 600 human umbilical vein endothelial cells (HUVECs) per spheroid, 200 thymus MSCs per spheroid, or 600 HUVECs plus 200
thymus MSCs per spheroid were generated (n = 3 per group) and were implanted subcutaneously for 14 days in NOD-SCID mice. Explanted
constructs were photographed (edges traced in A–D) and processed for histology. (A): Controls did not manifest local reaction. (B): HUVEC
constructs appeared avascular. (C): Thymus MSC constructs were integrated and caused increased adjacent vascularization. (D): HUVEC plus
thymus MSC constructs were integrated and surrounded by a host vascular response and appeared to have vessels within. (E–H): Construct
hematoxylin and eosin staining. Scale bars = 50mm. (E):Avascular tissue invasion of control construct. Scale bar = 100mm. (F):HUVEC construct
with adjacent cellularity and vascularity between panniculus carnosusmuscle layer (p) and construct. “Ghost” (†) of the prior locations of spher-
oid and necrotic spheroid (‡) were present in internal regions of all constructs with spheroids. (G): Thymus MSC construct with increased ad-
jacent cellularity and vascularity. (H): HUVEC plus thymus MSC construct with increased vascularization within the construct. (I): Manual
measurement of vessel density demonstrates significant differences by two-way analysis of variance. Control and HUVEC constructs had min-
imal adjacent vascularization. ThymusMSC constructs promoted the greatest adjacent response, whereas HUVEC plus thymusMSC constructs
contained thegreatest vessel densitywithin theconstruct. (J, K): Immunohistochemical stainingwithhuman-specific CD31monoclonal antibody
revealed that only constructs with HUVEC plus thymus MSCs contained CD31-positive luminal structures with blood cells. Scale bar = 20 mm.
Abbreviations: C, controls; H, human umbilical vein endothelial cell constructs; T, thymus mesenchymal stromal cell construct.
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[59, 60]. CD248 has also been demonstrated to play a role in pe-
ripheral lymph node and splenic expansion and regeneration [61,
62]. The significance of CD248 in the injury and regeneration of
other tissues has not been defined, although human bone mar-
row MSCs, rat adipose MSCs, and blood vessel-associated mural
cells express CD248, and an anti-CD248 antibody has been shown
to inhibit tube formation in bone marrow MSCs [63, 64].
We found that subcutaneously implanted constructs with
homotypic or heterotypic multicellular spheroids attracted host
dermal blood vessels, with thymus MSC spheroids inciting the
greatest response; however, the combinationofHUVECsplus thy-
mus MSCs yielded the greatest vascularization within the con-
struct. This indicates that the cooperation of both cell types
promoted the angioinvasion of the adjacent host dermal blood
vessels. Furthermore, only the combination of HUVECs plus thy-
mus MSCs yielded the formation of functional human blood ves-
sels, indicating that the importance of the interactions between
the two cell types in vasculogenesis. An alternative explanation
for the increase in surrounding vascular density is host NK cell-
mediated vascular changes because this immune cell is intact in
NOD-SCIDmice.Weperformed immunohistochemistry on earlier
(day7) explants todetermine thepresenceofNKcells (CD335)but
did not identify any within or around the construct, making NK
cell-mediated increase in vascular density less likely.
Although MSCs, with or without endothelial cells, have al-
ready been used by others to promote vascularization of
implanted constructs and ischemic tissues in both preclinical
and clinical settings [47, 65–69], the optimal MSC yielding the
maximal therapeutic angiogenic response has yet to be deter-
mined.Results presented in this studyandelsewhere suggest that
thymus MSCs may be a promising candidate for therapeutic use
[6, 7]. Given the low expression human leukocyte antigen class I
on a subset of neonatal human thymus MSCs, as shown in this
study and elsewhere [7, 70], use of these MSCs may also yield
advantages in the allogeneic setting (e.g., use in older patients
with ischemic heart disease), in which it is more likely to comple-
ment the advantages of neonatal MSCs over adult MSCs [71–73].
However, improvements in isolation yield are needed to make
clinical use of thymus MSCs feasible.
Other sources of MSCs and stem cells that may have thera-
peutic potential in neonates with heart disease include amniotic
fluid, placenta, umbilical cord, and Wharton’s jelly [32, 74–78].
MSCs have also been isolated from aborted fetuses [79]. Similar
to human neonatal thymus MSCs, fetal MSCs also had trilineage
differentiation capacity. The doubling time for fetal MSCs was
slightly less than what we observed in human thymus MSCs,
but the CFE was greater in human neonatal thymus MSCs. Like
neonatal thymus MSCs, fetal MSCs express pluripotency-related
genes such as Oct-4 and Nanog [80, 81]. Full characterization
and detailed comparison in relevant disease models are needed
to determine which MSC type will yield the optimal therapeutic
benefit.
CONCLUSION
MSCs are present in large numbers in discarded neonatal and in-
fant thymus tissue and can be isolated by an explant culture
method. Explant culture-isolated thymus MSCs demonstrate
the classical characteristics of bonemarrowMSCs. ThymusMSCs
also possess proangiogenic qualities and deserve further consid-
eration as a potential cell therapeutic agent to promote tissue re-
generation and repair and for use in strategies to vascularize
engineered tissues.
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